Print Page   |   Contact Us   |   Sign In   |   Join
News & Press: Industry Events

Altor BioScience Announces Upcoming Data Presentation at 2015 ASCO Annual Meeting

Thursday, May 28, 2015   (0 Comments)
Share |

Altor BioScience Announces Upcoming Data Presentation on Efficacy and Safety of ALT-801 for Advanced Bladder Cancer at 2015 ASCO Annual Meeting (May 28, 2015)


MIRAMAR, Fla.--(BUSINESS WIRE)--Altor BioScience Corporation (Altor), a leading developer of cancer immunotherapies, announced today that it will present updated safety and efficacy data from its ongoing Phase 1b/2 study of ALT-801 in combination with gemcitabine and cisplatin in patients with advanced or metastatic chemo-refractory urothelial cancer. The data will be presented in Poster Discussion Session at the upcoming 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place from May 29-June 2 in Chicago. Click here to view full release>>

Cantex Pharmaceuticals Announces Efficacy and Safety Data from Study of CX-01 in AML to be Presented at 2015 ASCO Annual Meeting

WESTON, Fla., May 18, 2015 /PRNewswire/ -- Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications that block critical mechanisms by which cancer spreads and resists treatment, today announced that an abstract revealing new data for Cantex's lead compound, CX-01, has been selected for a poster presentation at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 29 to June 2, 2015, in Chicago. Click here to view full press release>>

Tyrogenex Announces X-82 Poster Presentation at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting (May 28, 2015)
PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Tyrogenex, a privately held company focused on the development of next-generation targeted therapeutics for cancer and ophthalmology, today announced the release of one abstract for X-82 to be presented as a poster during the 2015 American Society for Clinical Oncology (ASCO) annual meeting held in Chicago May 29 through June 2. Click here to view full release>>  


Abbott

BioFlorida, Inc. | 901 NW 35th Street | Boca Raton, FL 33431
(P) 561-653-3839 (F) 561-653-3840 admin@bioflorida.com
Membership Management Software Powered by YourMembership  ::  Legal